GOT/AST UV 3 ML, 12 x 16 mL

    995899



    To access the documentation you must be registered

    Register


    Conformité européenne In vitro diagnostic product

    For in vitro determination of GOT/AST Transaminase in serum or plasma. 

    DOCUMENTS

    State Lyophilized
    Storage temp. +2 / +8 ºC
    Technique IFCC Method

    Documentation

    Only for registered users. Register here
    Current batch :

      Download
      Download
      Download
    Previous batches :

      Download

    PRINCIPLE

    The glutamic-oxalacetic transaminase (GOT), actually AST, catalyzes the reaction between L-aspartic acid and α-ketoglutaric acid. The oxalacetic acid formed is reduced by NADH with the aid of the auxiliary enzyme MDH.

    The change of NADH to NAD+ produces a change of Abs. The reaction media contains, also, LDH to remove endogenous pyruvate to avoid possible interferences. In optimum reaction conditions the ΔAbs/min is directly related to GOT concentration in the sample.

    DIAGNOSTIC USE

    Increments in GOT activity are observed in cases of liver damage: hepatitis of various types, necrosis or damage in hepatocytes, cholestatic icteria.

    High levels are also seen in heart muscle diseases. In alcoholic hepatitis and acute myocardial infarction, the increase of GOT activity is greater than that of GPT.

    Single test result can not be used to make a clinical diagnosis. It should integrate clinical and laboratory data.